Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 85416-75-7 | Product Number: R0182
(R)-(-)-Rolipram
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- (R)-(-)-4-[3-(Cyclopentyloxy)-4-methoxyphenyl]pyrrolidin-2-one
Product Documents:
| Size | Unit Price | Belgium | Japan* |
|---|---|---|---|
| 10MG |
€72.00
|
1 | Contact Us |
| 50MG |
€249.00
|
1 | 7 |
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | R0182 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__6H__2__1NO__3 = 275.35 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (<0°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 85416-75-7 |
| Reaxys Registry Number | 5442919 |
| PubChem Substance ID | 354333406 |
| MDL Number | MFCD03093861 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Optical purity(LC) | min. 98.0 ee% |
| Elemental analysis(Nitrogen) | 4.50 to 5.50 % |
| Melting point | 132.0 to 136.0 °C |
| Specific rotation [a]20/D | -29.0 to -34.0 deg(C=0.5, MeOH) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 134 °C |
| Specific Rotation | -32° (C=0.5,MeOH) |
GHS
Related Laws:
Transport Information:
| HS Number | 2933790090 |
Application
(R)-(-)-Rolipram: The Active Enantiomer of Rolipram, PDE4 Inhibitor
(R)-(-)-Rolipram is the active enantiomer of rolipram [R0110] which is a selective inhibitor of phosphodiesterases 4 (PDE4s). It has been reported that (R)-(-)-rolipram is approximately 3 times more potent than (S)-(+)-rolipram [R0183] against PDE4. In 2015, Kobayashi et al. have been reported a new multistep continuous-flow synthesis of (R)- and (S)-rolipram using only columns packed with heterogeneous catalysts. (The product is for research purpose only.)
References
- Stereospecific binding of the antidepressant rolipram to brain protein structures
- Pharmacokinetics of (+)-rolipram and (-)-rolipram in healthy volunteers
- Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase
- Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNFα generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer
- Rolipram and its optical isomers, phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats
- Multistep continuous-flow synthesis of (R)- and (S)-rolipram using heterogeneous catalysts
- Flow “Fine” Synthesis: High Yielding and Selective Organic Synthesis by Flow Methods
PubMed Literature
Articles/Brochures
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.